Skip to content

HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis

HED-Start: A Randomised Controlled Trial to Evaluate a Positive Skills Intervention for Patients New on Haemodialysis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04774770
Enrollment
148
Registered
2021-03-01
Start date
2021-01-05
Completion date
2024-06-30
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Kidney Disease, End Stage Renal Disease, End Stage Renal Disease on Dialysis, End Stage Renal Failure on Dialysis

Brief summary

Hemodialysis patients often experience barriers and misperceptions that hinder adjustment to life on dialysis. This study seeks to explore a group-based intervention (titled HED-Start) developed to improve self-care and emotional wellbeing among incident hemodialysis patients.

Detailed description

There are potentially modifiable psychosocial barriers and misperceptions about life on dialysis that hinder adjustment outcomes. It is hypothesized that these may include: poor understanding on what is needed or 'how to implement treatment principles', misperceptions related to disease and treatment, catastrophizing beliefs about impact of dialysis and low level of confidence on ability to manage treatment regime and renegotiate life roles as a dialysis patient. This study seeks to explore the feasibility and acceptability of implementing a two-arm parallel randomized controlled trial of a group-based intervention (titled HED-Start). HED-Start is specifically developed to reduce psychological distress and support self-care and self-management outcomes in incident hemodialysis patients. Drawing on self-management and motivational interviewing principles paradigm, the HED-Start program aims to facilitate acquisition of skills and knowledge to support and improve self-care and emotional adjustment outcomes.

Interventions

BEHAVIORALHED-Start

The HED-Start Program is a cognitive-behavioral intervention based on self-management and motivational interviewing principles.

Sponsors

National Kidney Foundation, Singapore
CollaboratorOTHER
Nanyang Technological University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Masking description

Care providers (dialysis nurses) and outcomes assessors (research staff conducting the baseline and follow-up questionnaires) will be blinded to participant allocation.

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with end-stage kidney disease (ESKD) and established on hemodialysis with the National Kidney Foundation Singapore (NKF) for fewer than 90 days * At least 21 years old * Proficient in spoken and written English or Mandarin

Exclusion criteria

* Unwilling or unable to give informed consent or refuse to be randomized * Have cognitive impairments or psychiatric conditions that preclude consent * Are currently involved in other intervention trials * Are failing on dialysis and approaching end of life (supportive/palliative care pathway)

Design outcomes

Primary

MeasureTime frameDescription
Change in Anxiety and Depression (HADS) scores from baselineParticipants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomizationHospital Anxiety and Depression Scale (HADS). The HADS comprises two subscales (anxiety; depression) and can be totaled to produce an overall scale score. Scores range from 0 to 21 for each subscale, and from 0 to 42 for the overall score. Higher scores are indicative of worse anxiety and depression symptoms.

Secondary

MeasureTime frameDescription
Change in kidney disease-related quality of life (KDQOL-SF) scores from baselineParticipants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomizationKidney Disease Quality of Life instrument (KDQOL-SF). The Burden of Kidney Disease subscale from the KDQOL-SF will be administered. Scores range from 0 to 100, with a higher score reflecting better quality of life.
Change in Illness Perception scores from baselineParticipants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomizationBrief Illness Perception Questionnaire (BIPQ). The BIPQ consists of 8 subscales (i.e., Consequence, Timeline, Identity, Personal Control, Treatment Control, Concern, Coherence, and Emotional Representation). Subscale scores range from 0 to 10, with higher scores reflective of more negative illness perceptions.
Change in Positive and Negative Affect scores from baselineParticipants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomizationScale of Positive and Negative Experience (SPANE). The SPANE comprises 6 items assessing positive affect and 6 items assessing negative affect. Subscale scores range from 6 to 30. Higher scores in the Positive and Negative affect subscale indicate greater positive and negative affect respectively.
Change in Quality of life (WHOQOL-BREF) scores from baselineParticipants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomizationWorld Health Organization Quality of Life instrument (WHOQOL-BREF). Two global items (overall quality of life; general health) and two subscales (psychological health; social relationships) from the WHOQOL-BREF are used. Global scores range from 1 to 5, while subscale scores range from 4 to 20. Higher scores indicate better quality of life.
Change in Benefit finding in hemodialysis (BFS) scores from baselineParticipants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomizationBenefit Finding Scale (BFS). Two subscales (personal growth; acceptance) and an overall score can be computed. All scores range from 1 to 4, with a higher score reflecting a greater extent of benefit finding.
Change in Resilience scores from baselineParticipants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomization2-item Connor-Davidson Resilience Scale (CD-RISC-2). The CD-RISC-2 score ranges from 0 to 8. Higher scores indicate greater resilience.
Change in Health Education Impact Questionnaire scores from baselineParticipants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomizationHealth Education Impact Questionnaire (heiQ). Six subscales from the heiQ (Positive and Active Engagement in Life, Skill and Technique Acquisition, Constructive Attitudes and Approaches, Self-Monitoring and Insight, Health Services Navigation, and Social Integration and Support) will be used to assess other self-management skills. Scores range from 1 to 4. Higher scores indicate greater proficiency with the relevant skill domain.
Change in Self-Efficacy for Managing Chronic Disease 6-item Scale scores from baselineParticipants will be assessed at two time points: [T1] Baseline and [T2] 3 months post-randomizationSelf-Efficacy for Managing Chronic Disease 6-item Scale. The overall scale score ranges from 1 to 10. Higher scores reflect greater self-efficacy.

Countries

Singapore

Contacts

Primary ContactKonstadina Griva, PhD
konstadina.griva@ntu.edu.sg+6569047348

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026